TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37

Benzinga · 3d ago
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.